手术引流设备市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、按应用、最终用途、地区、竞争细分

2022 年全球手术引流设备市场价值为25.2 亿美元，预计在预测期内将大幅增长，预计到2028 年复合年增长率将达到6.31%。这些医疗设备被称为手术引流管，具有促进手术引流的重要功能。从体腔或伤口排出液体和/或气体。手术引流管通常采用管子的形式，策略性地放置在术后患者手术伤口附近，以有效去除脓液、血液或其他液体等物质，从而防止它们在体内积聚。这些排水管持续发挥作用，有助于在受影响区域保持最佳压力梯度。

手术引流管有助于清除发炎介质、病原体、外来物和坏死组织，在癒合过程中发挥至关重要的作用。透过这样做，它们有助于预防恢復期间可能出现的併发症。此外，手术引流管使医疗保健专业人员能够在整个癒合过程中轻鬆取样，从而有助于监测潜在问题或併发症。

市场概况
预测期	2024-2028
2022 年市场规模	25.2亿美元
2028 年市场规模	36.5亿美元
2023-2028 年复合年增长率	6.31%
成长最快的细分市场	医院
最大的市场	北美洲

主要市场驱动因素

外科手术不断增加

随着外科手术数量的增加，对外科引流装置的需求也增加。这些设备对于管理术后积液至关重要，这是许多手术后常见的情况。外科医生和医疗保健提供者依靠这些设备来确保患者的正常癒合和康復。外科手术涉及广泛的医学专业，包括骨科、心血管、一般外科、妇科等。每个外科专业可能需要根据手术的独特需求客製化特定类型的引流装置。因此，外科手术的多样性导致了对各种引流设备的更广泛的需求，从而推动了市场的成长。微创手术技术的兴起增加了手术总数。 MIS 技术通常会产生较小的切口和较少的组织损伤，但它们仍需要引流来控制液体积聚。因此，MIS 的采用促进了对专用微创引流设备的需求增加。由于事故和不可预见的医疗状况，紧急手术（例如创伤手术或紧急干预）正在增加。在这些情况下，快速有效的引流解决方案对于预防併发症和支持患者康復至关重要。随着全球人口老化，需要手术介入的与年龄相关的健康问题的发生率更高。老年患者通常患有合併症，随着时间的推移可能需要多次手术。在这些病例中，随着术后护理变得更加重要，对手术引流装置的需求是显而易见的。糖尿病和心血管疾病等慢性疾病通常需要外科手术来控制併发症。慢性病患者可能定期接受手术，导致手术引流设备的持续需求。

技术进步

材料科学的进步导致了用于外科引流装置的更俱生物相容性和耐用性的材料的开发。这些材料可降低组织刺激和过敏反应的风险，同时提高设备的整体性能和使用寿命。增强型材料透过提高排水装置的接受度和采用率来促进市场的成长。技术创新促进了微创手术技术（MIS）的发展，与传统的开放性手术相比，微创手术需要更小的切口。 MIS 技术侵入性较小，通常可以缩短住院时间并加快復原速度。这种转变增加了对专用微创引流装置的需求，这些装置可以透过更小的切口有效地控制积液。改进的影像和视觉化技术，例如术中超音波和内视镜检查，可以帮助外科医生评估手术部位和引流的需要。这些技术有助于精确放置引流装置，降低併发症的风险并改善患者的治疗效果。将智慧技术整合到手术引流设备中可以实现即时监控和资料收集。智慧排水管可以测量和传输有关液体输出的信息，这有助于医疗保健提供者及时做出有关排水管理的决策。该技术改善了患者护理并减少了手动监测的需求，从而推动了此类设备的采用。技术使得引流装置的设计能够降低感染风险。抗菌涂层和具有抗菌特性的材料有助于降低设备上细菌定植的风险，从而最大限度地减少术后感染的机会。将远距医疗和远端监控解决方案整合到医疗保健系统中已经影响了手术引流设备市场。医疗保健提供者可以远端监控患者的引流输出并提供指导，从而减少频繁的现场追踪的需要并提高患者的便利性。

有利的监管环境

严格的监管标准和要求有助于确保手术引流装置符合高品质和安全标准。製造商必须遵守严格的品质控制流程，以生产可靠、安全的产品。这给医疗保健提供者註入了信心，并鼓励他们采用这些设备。有利的监管环境加快了製造商进入市场的进程。监管批准（例如欧洲的 CE 标誌或美国的 FDA 许可）对于医疗器材的营销至关重要。简化的监管流程可以减少与获得这些认证相关的时间和成本，使製造商能够更快地将其产品推向市场。监管机构通常要求手术引流装置遵守行业标准和指南。製造商必须投资于研发，以确保其设备符合这些标准，从而促进创新并推动改善排水技术的发展。监管机构强制要求上市后监督和不良事件报告。这项要求确保及时识别和解决手术引流装置的任何安全问题或问题。製造商必须在现场监控其产品并应对安全问题，最终生产出更安全的设备。监管部门的批准意味着手术引流装置已满足严格的安全性和有效性标准。此认证提高了该设备在医疗保健提供者眼中的可信度和可信度，促进其在临床环境中的采用和使用。符合国际标准的有利监管环境使製造商更轻鬆地进入全球市场。符合一个国家公认的监管标准的设备通常会被其他地区接受，从而减少进入新市场的障碍。一些监管机构透过赠款和资助计划支持医疗器材产业的创新和研究。这些措施可以激励製造商投资研发，以创造先进、更有效的手术引流设备。

主要市场挑战

监管障碍

获得外科引流装置的监管批准可能是一个漫长而复杂的过程。製造商必须提交全面的文件，进行广泛的测试，并满足严格的品质和安全标准。批准所需的时间和资源可能会延迟产品发布和市场进入，从而阻碍成长。遵守监管要求的成本可能很高。製造商必须投资于研究、测试、品质控制和文件记录。相关成本可能会让小公司望而却步，进而减少市场竞争和创新。不同的国家和地区往往有不同的医疗器材监管架构和标准。对于製造商来说，应对这些变化可能具有挑战性且成本高昂，特别是当他们寻求在全球范围内扩展其产品时。这种变化可能导致市场进入的延迟和费用的增加。监管机构要求对市场上的医疗器材进行持续监控。製造商必须报告不良事件并进行上市后监督，这可能会占用大量资源，并增加持续的营运成本。由于监管审查，一些製造商可能会规避风险，并在创新或为其产品引入新功能方面犹豫不决。这可能会减慢先进手术引流设备的开发和采用，限制市场成长。对于新进入者或规模较小的公司来说，监管要求可能是重大的进入障碍。克服这些障碍所需的时间和成本可能会阻碍竞争并限制创新设备的可用性。

激烈的比赛

激烈的竞争可能会导致价格战，製造商降低价格以获得市场份额。虽然这有利于医疗保健提供者和患者节省成本，但它可能会对製造商的收入和盈利能力产生负面影响。价格降低也会限制製造商投资研发的能力，可能阻碍先进和创新产品的推出。随着竞争压低价格，製造商的利润率可能会下降。这可能会限制他们再投资业务、扩大产能或从事行销和促销活动的能力。反过来，这可能会减缓整体市场的成长。激烈的竞争可能会激励一些製造商生产模仿现有手术引流装置的成功设计或功能的山寨产品。虽然这可以为医疗保健提供者带来更多选择，但可能会阻碍製造商之间的创新和差异化，从而可能抑制市场成长。在竞争激烈的市场中，製造商可能会急于推出新版本或型号的手术引流装置。这种快速的周转可能给必须不断适应新产品的医疗保健提供者带来挑战。它还可能导致市场分散并使供应链管理复杂化。激烈的竞争可能导致市场饱和，多家製造商提供类似的产品，几乎没有差异化。在这种情况下，新进入者越来越难以立足，可能限制市场扩张。为了保持竞争力，製造商可能会寻找降低生产成本的方法。虽然成本削减措施可以增强竞争力，但它们可能会损害产品品质和安全。这可能会导致监管问题、产品召回以及製造商声誉受损，最终阻碍市场成长。较小的製造商或新创公司可能会发现在竞争激烈的市场中与成熟的公司竞争具有挑战性。这可能会阻碍创新并限制新的、潜在颠覆性的手术引流技术或方法的进入。

主要市场趋势

微创方法

腹腔镜和内视镜等微创手术 (MIS) 技术需要专门的手术引流装置，旨在实现更小的切口和精确的引流。这导致对微创引流解决方案的需求不断增长，推动市场成长。微创方法可以减少对周围组织的创伤，从而减少术后併发症。然而，在这些手术中，适当的引流仍然至关重要，以防止积液和感染。专为 MIS 量身订做的手术引流装置可提高病患安全性，进而提高其采用率。与传统的开放性手术相比，微创手术通常会缩短住院时间。高效且有效的引流装置在管理术后积液、促进患者更快康復和降低医疗成本方面发挥关键作用。微创方法优先考虑患者的舒适度和更快的康復。使用不那么显眼且可增强移动性的微创引流装置有助于实现以患者为中心的护理，这是现代医疗保健的成长趋势。微创手术的兴起刺激了手术引流装置的技术创新。製造商正在开发具有精确控制机制、与 MIS 仪器相容以及人体工学设计等功能的设备，所有这些都增强了它们对医疗保健提供者的吸引力。微创技术正在应用于越来越多的外科专业，包括妇科、泌尿科、骨科和心血管外科。随着这些专业采用 MIS，对专用排水设备的需求持续成长，使市场多样化。微创引流装置透过有效管理积液同时最大程度地减少不适，有助于 MIS 手术的整体成功。这反过来又提高了患者满意度并加快康復速度，从而加强了微创方法的采用。虽然微创手术的初始设备成本可能较高，但较短的住院时间和降低的併发症发生率可以为医疗保健系统节省成本。这种成本效益进一步鼓励采用微创方法，包括使用专门的引流装置。随着新兴市场医疗保健基础设施的改善，微创技术和相关引流设备的采用正在增加。微创手术的扩张有助于全球手术引流设备市场的整体成长。

智慧互联排水设备

智慧引流设备可以监控并向医疗保健提供者和远端监控系统传输即时资料，例如液体输出和压力。这种能力可以实现主动的患者护理、及早发现问题并及时干预，最终改善患者的治疗结果。连接设备透过持续监控排水参数提供额外的安全保障。如果液体输出出现异常或突然变化，可以立即向医疗保健提供者发出警报，使他们能够立即采取行动以防止併发症，例如液体收集或感染。传统的人工监测排水装置是劳力密集的，并且可能容易出错。智慧型设备可自动收集资料，减轻医护人员的负担，并最大限度地降低记录引流资料不准确的风险。智慧引流设备提供的即时资料和见解使医疗保健提供者能够就引流管理做出更明智的决策。这可以带来更有效率和个性化的患者护理，确保引流水平保持在所需的范围内。智慧引流设备可以与远距医疗平台整合，使医疗保健提供者能够远端监控患者的术后进展。这种整合与远距医疗和远距医疗服务的日益普及相一致，扩大了医疗保健专业人员的覆盖范围并提高了患者的便利性。可以使用资料分析和人工智慧 (AI) 来分析连网排水设备收集的资料。这使得能够识别患者復健的模式和趋势，从而可用于预测目的。预测分析可以帮助医疗保健提供者预测併发症并相应地调整引流管理。智慧型设备简化监测流程，使医疗保健提供者能够将注意力集中在需要立即介入的患者上，从而促进更有效的资源分配。这可以节省医疗保健环境中的成本并提高资源利用率。连接引流设备透过提供持续监控和更快地回应患者需求，有助于以患者为中心的照护。这增强了术后护理期间患者的整体体验，并可能导致更高的患者满意度。监管机构正在认识到智慧互联医疗设备在提高病患安全方面的潜在好处。监管机构可能会鼓励采用此类设备，为製造商创造有利的环境并刺激市场成长。提供智慧连网引流设备的製造商透过提供满足医疗保健提供者和患者不断变化的需求的先进解决方案来获得竞争优势。这可以导致市场份额增加和收入成长。

细分市场洞察

应用洞察

根据该申请，预计胸腔外科和心血管外科领域在整个预测期内将大幅市场成长。胸部和心血管手术，例如心臟直视手术和血管手术，非常复杂，通常涉及重要结构的操作。包括冠状动脉疾病和瓣膜疾病在内的心臟相关疾病的盛行率不断增加，导致这些手术的数量增加。因此，这些手术领域对专用手术引流装置的需求也随之增加。胸部和心血管手术通常需要细緻的术后护理，包括积液的管理。手术引流装置透过促进从手术部位去除多余的液体而在这些手术中发挥关键作用。它们的有效使用对于预防併发症和确保患者康復至关重要。胸腔和心血管手术的复杂性需要精确且专业的工具和设备。专为这些手术设计的手术引流装置必须符合严格的品质和安全标准。此类专用设备的开发和采用有助于手术引流设备市场的成长。微创方法越来越多地应用于胸腔外科和心血管手术。这些技术需要针对较小切口和侵入性较小的手术量身定制的引流装置。随着这些技术的采用，对专业微创引流解决方案的需求也在增加。胸部和心血管手术后可能会发生术后併发症，例如胸腔积水或血肿形成。手术引流装置对于有效处理这些併发症至关重要。预防和治疗併发症的能力对于病人安全至关重要，从而推动了对引流装置的需求。胸腔和心血管手术的复杂性导致了手术引流装置设计的创新。製造商正在开发具有精确控制机制、与手术器械相容以及客製化引流解决方案等功能的设备，以满足这些手术的独特需求。介入性心臟病学和微创心臟手术（例如血管成形术和支架置入术）的发展增加了对适合这些微创方法的手术引流装置的需求。这一趋势支持了心血管领域的市场成长。

最终使用者见解

基于最终用户细分市场，医院细分市场一直是市场的主导力量。医院是手术引流装置的主要最终使用者之一。他们的购买决策对市场的成长有重大影响。随着医院扩大手术服务范围并进行更多手术，对手术引流设备的需求不断增加。医院优先考虑病患照护和安全。手术引流装置是术后照护的重要工具，有助于控制积液、预防併发症并促进患者復原。医院依靠这些设备来确保患者的健康，这推动了它们的持续使用和采用。医院的目标是尽量减少术后併发症，例如感染和积液。手术引流装置是实现这一目标的关键工具。它们的有效使用可以减少併发症的发生率，从而缩短住院时间并改善患者的治疗效果。医院处于采用新手术技术和技术的最前沿。随着微创手术和机器人辅助手术变得越来越普遍，医院寻求为这些手术设计的专门引流设备。这推动了先进手术引流解决方案的创新和开发。手术引流装置的使用已成为许多外科专业的护理标准。医院遵循建议使用这些设备的既定指南和最佳实践，有助于其持续的需求和市场成长。外科医生和其他医疗保健提供者根据他们的经验和设备的功效对特定的手术引流设备有偏好。医院通常会适应这些偏好，导致人们继续使用和购买首选设备。

区域洞察

北美，特别是手术引流设备市场，在 2022 年占据市场主导地位，这主要是因为北美，尤其是美国，是全球医疗保健支出率最高的国家之一。对医疗基础设施、设施和先进医疗技术（包括手术引流设备）的大量投资推动了市场成长。北美是医疗器材创新和研究的中心。该地区的特点是高度重视开发尖端外科技术和设备，其中包括不断改进外科引流设备。北美拥有大量患者，其中包括大量老年人口。与年龄相关的健康状况，例如心血管疾病和癌症，通常需要使用外科引流装置进行外科手术。该地区有大量的外科手术，包括选择性和非选择性手术。这些手术通常需要使用手术引流装置来处理术后併发症，这增加了需求。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球手术引流装置市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（主动、被动）
  • 按应用（胸腔及心血管手术、神经外科手术、腹部手术、骨科、其他）
  • 依最终用途（医院、门诊手术中心、诊所）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 按产品分类
  • 按应用
  • 按最终用途
  • 按地区

第 6 章：北美手术引流设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（主动、被动）
  • 按应用（胸腔及心血管手术、神经外科手术、腹部手术、骨科、其他）
  • 依最终用途（医院、门诊手术中心、诊所）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲手术引流设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（主动、被动）
  • 按应用（胸腔及心血管手术、神经外科手术、腹部手术、骨科、其他）
  • 依最终用途（医院、门诊手术中心、诊所）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：亚太地区手术引流设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（主动、被动）
  • 按应用（胸腔及心血管手术、神经外科手术、腹部手术、骨科、其他）
  • 依最终用途（医院、门诊手术中心、诊所）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲手术引流设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（主动、被动）
  • 按应用（胸腔及心血管手术、神经外科手术、腹部手术、骨科、其他）
  • 依最终用途（医院、门诊手术中心、诊所）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲手术引流装置市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（主动、被动）
  • 按应用（胸腔及心血管手术、神经外科手术、腹部手术、骨科、其他）
  • 依最终用途（医院、门诊手术中心、诊所）
  • 按国家/地区
• MEA：国家分析
  • 南非手术引流装置
  • 沙乌地阿拉伯手术引流装置
  • 阿联酋手术引流装置

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球手术引流装置市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • Acelity LP Inc.
  • Teleflex Incorporated.
  • Cardinal Health.
  • Medtronic PLC.
  • Cook Medical.
  • Stryker Corporation.
  • CR Bard.
  • Ethicon, Inc.
  • B. Braun Melsungen.
  • Medela A G.

第 16 章：策略建议

The Global Surgical Drainage Devices Market, valued at USD 2.52 Billion in 2022, is poised for substantial growth in the forecast period, projecting a robust CAGR of 6.31% through 2028. These medical devices, known as surgical drains, serve the vital function of facilitating the drainage of fluid and/or gas from bodily cavities or wounds. Surgical drains typically take the form of tubes strategically placed near surgical wounds in post-operative patients to effectively remove substances such as pus, blood, or other fluids, thereby preventing their accumulation within the body. These drains function continuously, helping to maintain an optimal pressure gradient in the affected areas.

Surgical drains play a crucial role in the healing process by aiding in the removal of inflammatory mediators, pathogens, foreign objects, and necrotic tissue. By doing so, they contribute to the prevention of complications that may arise during recovery. Moreover, surgical drains enable healthcare professionals to easily sample fluid throughout the healing journey, facilitating the monitoring of potential issues or complications.

In essence, the Global Surgical Drainage Devices Market is on a trajectory of significant growth due to the indispensable role played by surgical drains in post-operative care. Their ability to efficiently manage fluid drainage, prevent complications, and support the healing process underscores their importance in the field of healthcare.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 2.52 Billion
Market Size 2028	USD 3.65 Billion
CAGR 2023-2028	6.31%
Fastest Growing Segment	Hospitals
Largest Market	North America

Key Market Drivers

Rising Surgical Procedures

As the number of surgical procedures grows, so does the need for surgical drainage devices. These devices are essential for managing post-operative fluid accumulation, which is a common occurrence after many surgeries. Surgeons and healthcare providers rely on these devices to ensure the proper healing and recovery of patients. Surgical procedures span a wide range of medical specialties, including orthopedics, cardiovascular, general surgery, gynecology, and more. Each surgical specialty may require specific types of drainage devices tailored to the unique needs of the procedure. The diversity of surgical procedures thus leads to a broader demand for a variety of drainage devices, driving market growth. The rise of minimally invasive surgical techniques has increased the overall number of surgeries performed. MIS techniques often result in smaller incisions and less tissue damage, but they can still require drainage to manage fluid buildup. Consequently, the adoption of MIS has contributed to the increased demand for specialized minimally invasive drainage devices. Emergency surgeries, such as trauma surgeries or urgent interventions, are on the rise due to accidents and unforeseen medical conditions. In these cases, quick and effective drainage solutions are essential to prevent complications and support patient recovery. As the global population ages, there is a higher incidence of age-related health issues that require surgical intervention. Elderly patients often have comorbidities and may require multiple surgeries over time. The need for surgical drainage devices in these cases is pronounced, as post-operative care becomes more critical. Chronic diseases, such as diabetes and cardiovascular diseases, often require surgical procedures to manage complications. Patients with chronic conditions may undergo surgeries regularly, contributing to the sustained demand for surgical drainage devices.

Technological Advancements

Advancements in materials science have led to the development of more biocompatible and durable materials for surgical drainage devices. These materials reduce the risk of tissue irritation and allergic reactions while improving the overall performance and longevity of the devices. Enhanced materials contribute to the market's growth by increasing the acceptance and adoption of drainage devices. Technological innovations have facilitated the growth of minimally invasive surgical techniques (MIS), which require smaller incisions compared to traditional open surgeries. MIS techniques are less invasive and typically result in shorter hospital stays and quicker recoveries. This shift has increased the demand for specialized minimally invasive drainage devices that can effectively manage fluid accumulation through smaller incisions. Improved imaging and visualization technologies, such as intraoperative ultrasound and endoscopy, aid surgeons in assessing the surgical site and the need for drainage. These technologies help in precise placement of drainage devices, reducing the risk of complications and enhancing patient outcomes. The integration of smart technology into surgical drainage devices allows for real-time monitoring and data collection. Smart drains can measure and transmit information about fluid output, which aids healthcare providers in making timely decisions regarding drainage management. This technology improves patient care and reduces the need for manual monitoring, driving the adoption of such devices. Technology has enabled the design of drainage devices with features that reduce the risk of infections. Antimicrobial coatings and materials with antimicrobial properties can help mitigate the risk of bacterial colonization on the device, thereby minimizing the chances of post-operative infections. The integration of telemedicine and remote monitoring solutions into healthcare systems has impacted the surgical drainage devices market. Healthcare providers can remotely monitor patients' drainage output and provide guidance, reducing the need for frequent in-person follow-ups and improving patient convenience.

Favorable Regulatory Environment

Rigorous regulatory standards and requirements help ensure that surgical drainage devices meet high-quality and safety standards. Manufacturers are compelled to adhere to strict quality control processes, leading to the production of reliable and safe products. This instills confidence among healthcare providers and encourages them to adopt these devices. A favorable regulatory environment expedites the process of market entry for manufacturers. Regulatory approvals, such as CE Marking in Europe or FDA clearance in the United States, are essential for marketing medical devices. A streamlined regulatory process can reduce the time and cost associated with obtaining these certifications, allowing manufacturers to bring their products to market more quickly. Regulatory agencies often require surgical drainage devices to adhere to industry standards and guidelines. Manufacturers must invest in research and development to ensure their devices comply with these standards, fostering innovation and driving the development of improved drainage technologies. Regulatory bodies mandate post-market surveillance and adverse event reporting. This requirement ensures that any safety concerns or issues with surgical drainage devices are promptly identified and addressed. Manufacturers must monitor their products in the field and respond to safety concerns, ultimately leading to safer devices. Regulatory approval signifies that a surgical drainage device has met rigorous safety and efficacy standards. This certification enhances the credibility and trustworthiness of the device in the eyes of healthcare providers, facilitating its adoption and use in clinical settings. Favorable regulatory environments that align with international standards enable manufacturers to access global markets more easily. A device that complies with recognized regulatory standards in one country is often accepted in other regions, reducing barriers to entry into new markets. Some regulatory agencies support innovation and research in the medical device industry through grants and funding programs. These initiatives can incentivize manufacturers to invest in research and development to create advanced and more effective surgical drainage devices.

Key Market Challenges

Regulatory Hurdles

Obtaining regulatory approvals for surgical drainage devices can be a lengthy and intricate process. Manufacturers must submit comprehensive documentation, conduct extensive testing, and meet stringent quality and safety standards. The time and resources required for approvals can delay product launches and market entry, impeding growth. Complying with regulatory requirements can be expensive. Manufacturers must invest in research, testing, quality control, and documentation. The associated costs may be prohibitive for smaller companies, reducing competition and innovation in the market. Different countries and regions often have distinct regulatory frameworks and standards for medical devices. Navigating these variations can be challenging and costly for manufacturers, especially when they seek to expand their products globally. This variability can lead to delays in market entry and added expenses. Regulatory agencies require continuous monitoring of medical devices in the market. Manufacturers must report adverse events and conduct post-market surveillance, which can be resource-intensive and add ongoing costs to the operation. Due to the regulatory scrutiny, some manufacturers may become risk-averse and hesitant to innovate or introduce new features to their products. This can slow down the development and adoption of advanced surgical drainage devices, limiting market growth. For new entrants or smaller companies, the regulatory requirements can be significant barriers to entry. The time and costs associated with meeting these hurdles can discourage competition and limit the availability of innovative devices.

Intense Competition

Fierce competition can lead to price wars, with manufacturers reducing prices to gain market share. While this benefits healthcare providers and patients in terms of cost savings, it can negatively impact the revenue and profitability of manufacturers. Reduced prices can also limit the ability of manufacturers to invest in research and development, potentially hindering the introduction of advanced and innovative products. As competition drives down prices, manufacturers may experience thinner profit margins. This can limit their ability to reinvest in their businesses, expand production capacity, or engage in marketing and promotional activities. In turn, this may slow down the overall market growth. Intense competition may incentivize some manufacturers to create copycat products that mimic successful designs or features of existing surgical drainage devices. While this can lead to more choices for healthcare providers, it may discourage innovation and differentiation among manufacturers, potentially stifling market growth. In a highly competitive market, manufacturers may rush to introduce new versions or models of surgical drainage devices. This rapid turnover can create challenges for healthcare providers who must constantly adapt to new product offerings. It may also lead to fragmentation in the market and complicate supply chain management. Intense competition can lead to market saturation, where multiple manufacturers offer similar products with little differentiation. In such a scenario, it becomes increasingly difficult for new entrants to gain a foothold, potentially limiting market expansion. To remain competitive, manufacturers may look for ways to cut production costs. While cost-cutting measures can enhance competitiveness, they may compromise product quality and safety. This can lead to regulatory issues, product recalls, and damage to a manufacturer's reputation, ultimately hindering market growth. Smaller manufacturers or startups may find it challenging to compete with well-established companies in a highly competitive market. This can discourage innovation and limit the entry of new, potentially disruptive technologies or approaches to surgical drainage.

Key Market Trends

Minimally Invasive Approaches

Minimally invasive surgery (MIS) techniques, such as laparoscopy and endoscopy, require specialized surgical drainage devices designed for smaller incisions and precise drainage. This has led to a growing demand for minimally invasive drainage solutions, driving market growth. Minimally invasive approaches are associated with reduced trauma to surrounding tissues, resulting in fewer post-operative complications. However, proper drainage is still crucial in these procedures to prevent fluid accumulation and infections. Surgical drainage devices tailored for MIS enhance patient safety, leading to their increased adoption. Minimally invasive surgeries often result in shorter hospital stays compared to traditional open surgeries. Efficient and effective drainage devices play a critical role in managing post-operative fluid accumulation, facilitating quicker patient recovery, and reducing healthcare costs. Minimally invasive approaches prioritize patient comfort and faster recuperation. The use of minimally invasive drainage devices that are less obtrusive and offer enhanced mobility contributes to patient-centered care, which is a growing trend in modern healthcare. The rise of minimally invasive surgery has spurred technological innovations in surgical drainage devices. Manufacturers are developing devices with features like precise control mechanisms, compatibility with MIS instruments, and ergonomic designs, all of which enhance their appeal to healthcare providers. Minimally invasive techniques are being applied to an increasing number of surgical specialties, including gynecology, urology, orthopedics, and cardiovascular surgery. As these specialties adopt MIS, the demand for specialized drainage devices continues to grow, diversifying the market. Minimally invasive drainage devices contribute to the overall success of MIS procedures by effectively managing fluid accumulation while minimizing discomfort. This, in turn, promotes patient satisfaction and faster recovery, reinforcing the adoption of minimally invasive approaches. While the initial equipment costs for minimally invasive surgery can be higher, the shorter hospital stays and reduced complication rates can result in cost savings for healthcare systems. This cost-efficiency further encourages the adoption of minimally invasive approaches, including the use of specialized drainage devices. As healthcare infrastructure improves in emerging markets, the adoption of minimally invasive techniques and associated drainage devices is on the rise. This expansion of minimally invasive surgeries contributes to the overall growth of the global surgical drainage devices market.

Smart and Connected Drainage Devices

Smart drainage devices can monitor and transmit real-time data, such as fluid output and pressure, to healthcare providers and remote monitoring systems. This capability allows for proactive patient care, early detection of issues, and timely interventions, ultimately improving patient outcomes. Connected devices provide an added layer of safety by continuously monitoring drainage parameters. In the event of anomalies or sudden changes in fluid output, healthcare providers can be alerted promptly, enabling them to take immediate action to prevent complications, such as fluid collection or infection. Traditional manual monitoring of drainage devices is labor-intensive and may be prone to errors. Smart devices automate data collection, reducing the burden on healthcare staff and minimizing the risk of inaccuracies in recording drainage data. The real-time data and insights provided by smart drainage devices enable healthcare providers to make more informed decisions regarding drainage management. This can lead to more efficient and personalized patient care, ensuring that drainage levels are kept within the desired range. Smart drainage devices can be integrated with telemedicine platforms, allowing healthcare providers to remotely monitor patients' post-operative progress. This integration aligns with the growing adoption of telehealth and telemedicine services, expanding the reach of healthcare professionals and improving patient convenience. The data collected by connected drainage devices can be analyzed using data analytics and artificial intelligence (AI). This enables the identification of patterns and trends in patient recovery, which can be used for predictive purposes. Predictive analytics can help healthcare providers anticipate complications and adjust drainage management accordingly. Smart devices facilitate more efficient resource allocation by streamlining the monitoring process and enabling healthcare providers to focus their attention on patients who require immediate intervention. This can lead to cost savings and improved resource utilization in healthcare settings. Connected drainage devices contribute to patient-centered care by offering continuous monitoring and quicker response times to patient needs. This enhances the overall patient experience during post-operative care and may lead to higher patient satisfaction rates. Regulatory agencies are recognizing the potential benefits of smart and connected medical devices in improving patient safety. Regulatory bodies may encourage the adoption of such devices, creating a favorable environment for manufacturers and stimulating market growth. Manufacturers offering smart and connected drainage devices gain a competitive advantage by providing advanced solutions that meet the evolving needs of healthcare providers and patients. This can lead to increased market share and revenue growth.

Segmental Insights

Application Insights

Based on the Application, the thoracic and cardiovascular surgeries segment is anticipated to witness substantial market growth throughout the forecast period. Thoracic and cardiovascular surgeries, such as open-heart procedures and vascular surgeries, are intricate and often involve the manipulation of vital structures. The increasing prevalence of heart-related conditions, including coronary artery disease and valvular disorders, has led to a higher volume of these surgeries. As a result, the demand for specialized surgical drainage devices in these surgical fields has also increased. Thoracic and cardiovascular surgeries typically require meticulous post-operative care, including the management of fluid accumulation. Surgical drainage devices play a critical role in these procedures by facilitating the removal of excess fluids from the surgical site. Their efficient use is essential in preventing complications and ensuring patient recovery. The complex nature of thoracic and cardiovascular surgeries demands precision and specialized tools and devices. Surgical drainage devices designed specifically for these procedures must meet stringent quality and safety standards. The development and adoption of such specialized devices contribute to the growth of the surgical drainage devices market. Minimally invasive approaches are increasingly utilized in thoracic and cardiovascular surgeries. These techniques require drainage devices tailored to smaller incisions and less invasive procedures. The demand for specialized minimally invasive drainage solutions has grown in parallel with the adoption of these techniques. Post-operative complications, such as pleural effusion or hematoma formation, can occur after thoracic and cardiovascular surgeries. Surgical drainage devices are essential for managing these complications effectively. The ability to prevent and treat complications is crucial for patient safety, driving the demand for drainage devices. The complexity of thoracic and cardiovascular surgeries has led to innovations in surgical drainage device design. Manufacturers are developing devices with features such as precise control mechanisms, compatibility with surgical instruments, and tailored drainage solutions to meet the unique demands of these procedures. The growth of interventional cardiology and minimally invasive cardiac procedures, such as angioplasty and stent placement, has increased the demand for surgical drainage devices that are suitable for these less invasive approaches. This trend supports market growth in the cardiovascular segment.

End User Insights

Based on the End User segment, the Hospitals segment has been the dominant force in the market. Hospitals are among the primary end-users of surgical drainage devices. Their purchasing decisions significantly impact the market's growth. As hospitals expand their surgical services and perform a higher volume of procedures, the demand for surgical drainage devices increases. Hospitals prioritize patient care and safety. Surgical drainage devices are essential tools in post-operative care, helping manage fluid accumulation, prevent complications, and promote patient recovery. Hospitals rely on these devices to ensure the well-being of their patients, which drives their consistent use and adoption. Hospitals aim to minimize post-operative complications, such as infections and fluid accumulation. Surgical drainage devices are key instruments in achieving this goal. Their effective use can reduce the incidence of complications, resulting in shorter hospital stays and better patient outcomes. Hospitals are at the forefront of adopting new surgical techniques and technologies. As minimally invasive and robotic-assisted surgeries become more common, hospitals seek specialized drainage devices designed for these procedures. This drives innovation and the development of advanced surgical drainage solutions. The use of surgical drainage devices has become a standard of care in many surgical specialties. Hospitals follow established guidelines and best practices that recommend the use of these devices, contributing to their consistent demand and market growth. Surgeons and other healthcare providers have preferences for specific surgical drainage devices based on their experience and the devices' efficacy. Hospitals often accommodate these preferences, leading to the continued use and purchase of preferred devices.

Regional Insights

North America, specifically the Surgical Drainage Devices Market, dominated the market in 2022, primarily due to North America, particularly the United States, has one of the highest healthcare expenditure rates globally. The substantial investment in healthcare infrastructure, facilities, and advanced medical technologies, including surgical drainage devices, drives market growth. North America is a hub for medical device innovation and research. The region is characterized by a strong focus on developing cutting-edge surgical technologies and devices, which includes the continuous improvement of surgical drainage devices. North America has a sizable patient pool, including a significant elderly population. Age-related health conditions, such as cardiovascular diseases and cancer, often necessitate surgical procedures that require the use of surgical drainage devices. The region witnesses a high volume of surgical procedures, both elective and non-elective. These surgeries often require the use of surgical drainage devices to manage post-operative complications, thereby increasing demand.

Key Market Players

• Acelity L.P Inc.

• Teleflex Incorporated.

• Cardinal Health.

• Medtronic PLC.

• Cook Medical.

• Stryker Corporation.

• C.R. Bard.

• Ethicon, Inc.

• B. Braun Melsungen.

• Medela A G

Report Scope:

In this report, the Global Surgical Drainage Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Surgical Drainage Devices Market, By Product:

• Active
• Passive

Surgical Drainage Devices Market, By Application:

• Thoracic & Cardiovascular Surgeries
• Neurosurgical Procedures
• Abdominal Surgery
• Orthopedics
• Others

Surgical Drainage Devices Market, By End Use:

• Hospitals
• Ambulatory surgical centers
• Clinics

Surgical Drainage Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Surgical Drainage Devices Market.

Available Customizations:

• Global Surgical Drainage Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Surgical Drainage Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Active, Passive)
    • 5.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 5.2.1.2 By Passive (Penrose Drain, Others)
  • 5.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 5.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Product
  • 5.3.2 By Application
  • 5.3.3 By End-Use
  • 5.3.4 By Region

6. North America Surgical Drainage Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Active, Passive)
    • 6.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 6.2.1.2 By Passive (Penrose Drain, Others)
  • 6.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 6.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Surgical Drainage Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Surgical Drainage Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Surgical Drainage Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Surgical Drainage Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Active, Passive)
    • 7.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 7.2.1.2 By Passive (Penrose Drain, Others)
  • 7.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 7.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Surgical Drainage Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. Germany Surgical Drainage Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Surgical Drainage Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Surgical Drainage Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Surgical Drainage Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia-Pacific Surgical Drainage Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Active, Passive)
    • 8.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 8.2.1.2 By Passive (Penrose Drain, Others)
  • 8.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 8.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Surgical Drainage Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Surgical Drainage Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Surgical Drainage Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Surgical Drainage Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Surgical Drainage Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. South America Surgical Drainage Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Active, Passive)
    • 9.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 9.2.1.2 By Passive (Penrose Drain, Others)
  • 9.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 9.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Surgical Drainage Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. Argentina Surgical Drainage Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. Colombia Surgical Drainage Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. Middle East and Africa Surgical Drainage Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Active, Passive)
    • 10.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 10.2.1.2 By Passive (Penrose Drain, Others)
  • 10.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 10.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Surgical Drainage Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Saudi Arabia Surgical Drainage Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. UAE Surgical Drainage Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Surgical Drainage Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Acelity L.P Inc.
  • 15.6.2 Teleflex Incorporated.
  • 15.6.3 Cardinal Health.
  • 15.6.4 Medtronic PLC.
  • 15.6.5 Cook Medical.
  • 15.6.6 Stryker Corporation.
  • 15.6.7 C.R. Bard.
  • 15.6.8 Ethicon, Inc.
  • 15.6.9 B. Braun Melsungen.
  • 15.6.10 Medela A G.

16. Strategic Recommendations